blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP3345928

EP3345928 - HUMAN CD3 BINDING ANTIBODY [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  30.04.2021
Database last updated on 05.10.2024
FormerThe patent has been granted
Status updated on  22.05.2020
FormerGrant of patent is intended
Status updated on  13.01.2020
FormerRequest for examination was made
Status updated on  08.06.2018
Most recent event   Tooltip15.07.2022Lapse of the patent in a contracting state
New state(s): MK
published on 17.08.2022  [2022/33]
Applicant(s)For all designated states
Merus N.V.
Yalelaan 62
3584 CM Utrecht / NL
[2018/28]
Inventor(s)01 / Bakker, Alexander Berthold Hendrik
c/o Merus N. V.
Yalelaan 62
3584 CM Utrecht / NL
02 / Van Loo, Pieter Fokko
c/o Merus N.V.
Yalelaan 62
3584 CM Utrecht / NL
 [2019/04]
Former [2018/28]01 / Bakker, Alexander Berthold Hendrik
c/o Padualaan 8, postvak 133
3584 CH Utrecht / NL
02 / Van Loo, Pieter Fokko
c/o Padualaan 8, postvak 133
3584 CH Utrecht / NL
Representative(s)V.O.
P.O. Box 87930
Carnegieplein 5
2508 DH Den Haag / NL
[2018/28]
Application number, filing date18152578.308.07.2016
[2018/28]
Priority number, dateEP2015017635510.07.2015         Original published format: EP 15176355
[2018/28]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP3345928
Date:11.07.2018
Language:EN
[2018/28]
Type: B1 Patent specification 
No.:EP3345928
Date:24.06.2020
Language:EN
[2020/26]
Search report(s)(Supplementary) European search report - dispatched on:EP04.05.2018
ClassificationIPC:C07K16/28, A61K39/395, // A61K39/00
[2018/28]
CPC:
C07K16/2809 (EP,KR,US); A61K39/39591 (EP,US); A61P35/00 (EP);
A61P35/02 (EP); C07K16/2851 (EP,KR,US); C07K2317/21 (KR,US);
C07K2317/31 (EP,KR,US); C07K2317/51 (KR,US); C07K2317/515 (US);
C07K2317/52 (KR); C07K2317/524 (EP,US); C07K2317/526 (EP,US);
C07K2317/53 (KR,US); C07K2317/55 (EP,KR,US); C07K2317/56 (EP,KR,US);
C07K2317/71 (EP,KR,US); C07K2317/73 (EP,US); C07K2317/734 (KR);
C07K2317/92 (EP,US); C07K2317/94 (EP,US) (-)
Designated contracting statesAL,   AT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MK,   MT,   NL,   NO,   PL,   PT,   RO,   RS,   SE,   SI,   SK,   SM,   TR [2018/28]
TitleGerman:HUMANES CD3 BINDENDER ANTIKÖRPER[2018/28]
English:HUMAN CD3 BINDING ANTIBODY[2018/28]
French:ANTICORPS DE LIAISON CD3 HUMAIN[2018/28]
Examination procedure19.01.2018Examination requested  [2018/28]
19.01.2018Date on which the examining division has become responsible
22.02.2019Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time
07.03.2019Amendment by applicant (claims and/or description)
14.01.2020Communication of intention to grant the patent
15.05.2020Fee for grant paid
15.05.2020Fee for publishing/printing paid
15.05.2020Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP16178648.8  / EP3115376
Divisional application(s)EP20174449.7  / EP3757129
Opposition(s)25.03.2021No opposition filed within time limit [2021/22]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
07.03.2019Request for further processing filed
07.03.2019Full payment received (date of receipt of payment)
Request granted
18.03.2019Decision despatched
The application is deemed to be withdrawn due to failure to indicate the wish to proceed further with the application
07.03.2019Request for further processing filed
07.03.2019Full payment received (date of receipt of payment)
Request granted
18.03.2019Decision despatched
Fees paidRenewal fee
20.06.2018Renewal fee patent year 03
25.06.2019Renewal fee patent year 04
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU08.07.2016
AL24.06.2020
AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
MK24.06.2020
MT24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
SM24.06.2020
TR24.06.2020
LU08.07.2020
BE31.07.2020
CH31.07.2020
LI31.07.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
[2022/33]
Former [2022/27]HU08.07.2016
AL24.06.2020
AT24.06.2020
CY24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
MT24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
SM24.06.2020
TR24.06.2020
LU08.07.2020
BE31.07.2020
CH31.07.2020
LI31.07.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/36]AL24.06.2020
AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SI24.06.2020
SK24.06.2020
SM24.06.2020
LU08.07.2020
BE31.07.2020
CH31.07.2020
LI31.07.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/24]AL24.06.2020
AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SK24.06.2020
SM24.06.2020
LU08.07.2020
BE31.07.2020
CH31.07.2020
LI31.07.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/20]AL24.06.2020
AT24.06.2020
CZ24.06.2020
DK24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SK24.06.2020
SM24.06.2020
LU08.07.2020
CH31.07.2020
LI31.07.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/18]AL24.06.2020
AT24.06.2020
CZ24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
MC24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SK24.06.2020
SM24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/10]AL24.06.2020
AT24.06.2020
CZ24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
PL24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SK24.06.2020
SM24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
IS24.10.2020
PT26.10.2020
Former [2021/09]AL24.06.2020
AT24.06.2020
CZ24.06.2020
EE24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
RO24.06.2020
RS24.06.2020
SE24.06.2020
SM24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
PT26.10.2020
Former [2021/04]AL24.06.2020
FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
RS24.06.2020
SE24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
Former [2021/01]FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
RS24.06.2020
SE24.06.2020
BG24.09.2020
NO24.09.2020
GR25.09.2020
Former [2020/51]FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
RS24.06.2020
SE24.06.2020
NO24.09.2020
GR25.09.2020
Former [2020/50]FI24.06.2020
HR24.06.2020
LT24.06.2020
LV24.06.2020
SE24.06.2020
NO24.09.2020
GR25.09.2020
Former [2020/48]FI24.06.2020
LT24.06.2020
SE24.06.2020
NO24.09.2020
Former [2020/47]LT24.06.2020
NO24.09.2020
Documents cited:Search[AD]WO2014061433  (IHI CORP [JP]) [AD] 1-19* See examples;; claims 1-27 *
by applicantUS2003078385
 WO2004009618
 WO2005118635
 WO2009157771
 WO2013157954
 WO2014051433
 US9248181
 US9358286
    - UniProtKB, Database accession no. Q02223
    - UniProtKB, Database accession no. P15391
    - UniProtKB, Database accession no. P11836
    - UniProtKB, Database accession no. P28908
    - UniProtKB, Database accession no. P20138
    - UniProtKB, Database accession no. P28907
    - UniProtKB, Database accession no. P16070
    - UniProtKB, Database accession no. 075794
    - UniProtKB, Database accession no. P18827
    - UniProtKB, Database accession no. P06731
    - BAKKER A. et al., Cancer Res., (20040000), vol. 64, pages 8843 - 8850
    - pROTEIN, Database accession no. AY547296
    - Protein, Database accession no. AF247788
    - A.S. MARSHALL et al., J Biol Chem, (20040000), vol. 279, pages 14792 - 14802
    - Gene, Database accession no. AY498550
    - Y.HAN et al., Blood, (20040000), vol. 104, pages 2858 - 2866
    - Gene, Database accession no. AY426759
    - C.H.CHEN et al., Blood, (20060000), vol. 107, pages 1459 - 1467
    - UniProtKB, Database accession no. Q5QGZ9
    - VAN RHENEN et al., Blood, (20070000), vol. 110, page 2659
    - MOSHAVER et al., Stem Cells, (20080000), vol. 26, page 3059
    - UniProtKB, Database accession no. 075390
    - UniProtKB, Database accession no. P00533
    - Oncogene, (20130523), vol. 32, no. 21, pages 2670 - 2681
    - UniProtKB, Database accession no. Q9NYJ7
    - UniProtKB, Database accession no. Q13421
    - UniProtKB, Database accession no. P15328
    - UniProtKB, Database accession no. P41439
    - UniProtKB, Database accession no. P16422
    - UniProtKB, Database accession no. P04626
    - UniProtKB, Database accession no. Q10589
    - UniProtKB, Database accession no. P49901
    - UniProtKB, Database accession no. Q04609
    - SPIESS, C. et al., "Alternative molecular formats and therapeutic applications for bispecific antibodies", Mol. Immunol., (20150000), URL: http: //dx.doi.org/10.1016/j.molimm.2015.01.003
    - CUI et al., JBC, (20120000), vol. 287, pages 28206 - 28214
    - KONTERMANN, MABS, (20120000), vol. 4, pages 182 - 197
    - CHAMES; BATY, MABS, (20090000), vol. 1, pages 539 - 547
    - MOORE et al., Blood, (20110000), vol. 117, pages 4542 - 4551
    - LOFFLER et al., Blood, (20000000), vol. 95, page 2098
    - ZEIDLER et al., J. Immunol., (19990000), vol. 163, page 1246
    - GUNASEKARAN et al., JBC, (20100000), vol. 285, pages 19637 - 19646
    - SALI et al., J. Mol. Biol., (19930000), vol. 234, pages 779 - 815
    - LIU et al., Journal of Pharmaceutical Sciences, (20080000), vol. 97, pages 2426 - 2447
    - DE KRUIF et al., Biotechnol Bioeng, (20100000), vol. 106, pages 741 - 750
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.